GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
The purchase aims to build GSK’s oncology pipeline.
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion

The purchase aims to build GSK’s oncology pipeline.

The purchase aims to build GSK’s oncology pipeline.

Glaxosmithkline
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Novartis and Sanofi Stockpile Meds in Preparation for Brexit
Ashley Yeager | Aug 3, 2018
If the UK leaves the EU in March without a deal, transport of insulin and other essential drugs could be delayed.
Layoffs, Restructuring at GSK
Layoffs, Restructuring at GSK
Tracy Vence | Dec 4, 2014
GlaxoSmithKline is eliminating 900 US jobs—most in R&D.
Uncloaking Clinical Trials
Uncloaking Clinical Trials
Beth Marie Mole | Oct 17, 2012
Glaxo­SmithKline will share long-sought, raw trial data—but access will be tightly controlled.